Vitamin D and irritable bowel syndrome in children

Vitamin D intervention in adolescents with irritable bowel syndrome

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201704002162350

Enrollment

150

Registered

2017-03-31

Start date

2014-03-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Digestive System Paediatrics irritable bowel syndrome

Interventions

vitamin D supplementation

nothing taken

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: adolescent diagnosed with IBS depending on Rome III criteria for diagnosis of childhood irritable bowel syndrome with normal serum vitamin D level.

Exclusion criteria

Exclusion criteria: 1- children with recent use of antibiotics (4 weeks) 2-recent change in IBS therapy, history of gut surgery or radiation, celiac disease 3-chronic drug therapy, children with body mass index (BMI) of less than 18 or more than 25 4-chronic disease such as renal failure or diabetes mellitus 5-patients taking vitamin D supplementation.

Design outcomes

Primary

Measure	Time frame
improvement of irritable bowel syndrome symptoms	—

Secondary

Measure	Time frame
serum level of vitamin D	—

Countries

Egypt

Contacts

Public Contactmohamed El Kashlan

consultant

mohamedkashlan@yahoo.com+201222337746

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026